HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists.

Abstract
The functional role of metabotropic glutamate receptor (mGluR) activation was investigated following intracerebral administration of 1S,3R-ACPD in mice. Injections of 1S,3R-ACPD (50-800 nmol in 5 microliters) into the thalamus produced a dose-dependent increase in limbic seizures. These effects were stereoselective since 1R,3S-ACPD, did not elicit seizure activity. Pharmacologically, limbic seizures were attenuated by the mGluR partial agonist/antagonist L-2-amino-3-phosphonopropionate (L-AP3) and dantrolene, an inhibitor of intracellular calcium mobilization, but not by D-AP3 or ionotropic glutamate receptor antagonists (MK-801 or GYKI-52466). Thus, activation of mGluRs by 1S,3R-ACPD in mice, induces limbic seizures that may involve the mobilization of intracellular calcium stores.
AuthorsJ P Tizzano, K I Griffey, J A Johnson, A S Fix, D R Helton, D D Schoepp
JournalNeuroscience letters (Neurosci Lett) Vol. 162 Issue 1-2 Pg. 12-6 (Nov 12 1993) ISSN: 0304-3940 [Print] Ireland
PMID8121613 (Publication Type: Journal Article)
Chemical References
  • Anticonvulsants
  • Receptors, Amino Acid
  • Receptors, Metabotropic Glutamate
  • Cycloleucine
  • 1-amino-1,3-dicarboxycyclopentane
Topics
  • Animals
  • Anticonvulsants (pharmacology)
  • Cycloleucine (administration & dosage, analogs & derivatives, pharmacology)
  • Dose-Response Relationship, Drug
  • Hippocampus (anatomy & histology)
  • Injections
  • Limbic System (physiology)
  • Male
  • Mice
  • Receptors, Amino Acid (antagonists & inhibitors)
  • Receptors, Metabotropic Glutamate (antagonists & inhibitors)
  • Seizures (chemically induced, physiopathology)
  • Signal Transduction (drug effects)
  • Stereoisomerism
  • Thalamus (anatomy & histology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: